Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Biogen
Company Monitoring Page for Biogen
latest headlines for company on cafepharma
Biogen CEO says company 'lost its way,' cuts $125M MS partnership amid declining revenue
Endpoints
Wed, 02/15/23 - 06:30 pm
Tags:
Biogen
,
InnoCare Pharma
,
orelabrutinib
,
earnings
Biogen chairman to step down as new CEO walks thin line with Alzheimer's launch Leqembi
Fierce Pharma
Wed, 02/15/23 - 06:26 pm
Tags:
Biogen
,
Chris Viehbacher
,
Stelios Papadopoulos
,
Pharma CEOs
,
Alzheimer's disease
,
Leqembi
FDA adds warning of 'larger areas of bleeding' in brain to Biogen's Aduhelm label
Endpoints
Tue, 02/14/23 - 11:01 am
Tags:
Biogen
,
Aduhelm
,
FDA
,
Alzheimer's disease
Biogen, Sage Get FDA Priority Review of Zuranolone
Marketwatch
Mon, 02/6/23 - 10:47 am
Tags:
Biogen
,
SAGE Therapeutics
,
FDA
,
zuranolone
,
priority review
,
postpartum depression
,
major depressive disorder
Biogen/ Ionis ALS therapy set for March FDA AdCom meeting
Seeking Alpha
Mon, 01/23/23 - 11:12 am
Tags:
Biogen
,
Ionis Pharmaceuticals
,
FDA
,
ALS
,
tofersen
Why Biogen's Stock Isn't Soaring Since Its Alzheimer's Drug Got Approval
Motley Fool
Thu, 01/19/23 - 10:15 am
Tags:
Biogen
,
Eisai
,
Alzheimer's disease
,
Leqembi
,
lecanemab
New Biogen CEO tips subcutaneous lecanemab to help expansion into pre-symptomatic Alzheimer’s
Fierce Pharma
Fri, 01/13/23 - 10:59 am
Tags:
Biogen
,
Chris Viehbacher
,
lecanemab
,
Alzheimer's disease
,
Pharma CEOs
Alzheimer’s disease trials: How does Lilly’s donanemab compare to lecanemab?
Clinical Trials Arena
Fri, 01/13/23 - 10:49 am
Tags:
clinical trials
,
Alzheimer's disease
,
Eisai
,
Biogen
,
Eli Lilly
,
Leqembi
,
lecanemab
,
donanemab
After FDA nod, Eisai and Biogen file lecanemab in EU
Pharmaphorum
Wed, 01/11/23 - 11:04 pm
Tags:
Eisai
,
Biogen
,
lecanemab
,
Europe
,
Alzheimer's disease
Lilly, Biogen and more gear up for blockbuster launches in 2023: report
Fierce Pharma
Wed, 01/11/23 - 11:00 pm
Tags:
Clarivate
,
drug launches
,
Eli Lilly
,
Biogen
,
GSK
,
Bristol Myers Squibb
Biogen, scrapping for SMA market share, bets $10M on implant to improve delivery of Spinraza
Fierce Pharma
Tue, 01/10/23 - 10:55 am
Tags:
Biogen
,
Alcyone Therapeutics
,
SMA
,
Spinraza
,
devices
,
Medtech
Eisai learns from Biogen’s Aduhelm disaster
EP Vantage
Mon, 01/9/23 - 10:35 am
Tags:
Eisai
,
Biogen
,
Leqembi
,
Aduhelm
,
Alzheimer's disease
,
drug pricing
Eisai, in pricing new Alzheimer’s drug, tries to sidestep controversy
BioPharma Dive
Sun, 01/8/23 - 10:04 pm
Tags:
Eisai
,
Biogen
,
drug pricing
,
Leqembi
,
Alzheimer's disease
,
lecanemab
FDA approves Alzheimer’s drug from Eisai, Biogen in closely watched decision
BioPharma Dive
Fri, 01/6/23 - 03:40 pm
Tags:
Eisai
,
Biogen
,
lecanemab
,
Leqembi
,
Alzheimer's disease
,
FDA
Biogen and Alcyone Therapeutics partner up on novel device for neurological ASO therapies
Biopharma Reporter
Thu, 01/5/23 - 04:56 pm
Tags:
devices
,
Medtech
,
Biogen
,
Alcyone Therapeutics
,
ThecaFlex DRx
,
ASO therapies
Biogen splits R&D executive role, promoting interim head Singhal
BioPharma Dive
Thu, 01/5/23 - 04:47 pm
Tags:
Biogen
,
R&D
Biogen, FDA's inappropriate Aduhelm coordination detailed in blistering congressional report
Fierce Pharma
Fri, 12/30/22 - 10:50 am
Tags:
Biogen
,
Aduhelm
,
Alzheimer's disease
,
FDA
,
US Congress
Eisai and Biogen’s latest Alzheimer’s drug needs to be cheaper than the last one, analysts say
Stat
Thu, 12/22/22 - 11:10 am
Tags:
Biogen
,
Eisai
,
Alzheimer's disease
,
drug pricing
,
ICER
,
lecanemab
3rd patient death potentially tied to Eisai's Alzheimer's drug reported
Fierce Biotech
Thu, 12/22/22 - 11:05 am
Tags:
Biogen
,
Eisai
,
Alzheimer's disease
,
clinical trials
,
patient deaths
,
lecanemab
Ahead of lecanemab decision, Alzheimer's groups petition CMS to reverse coverage policy
Endpoints
Wed, 12/21/22 - 11:31 am
Tags:
Biogen
,
FDA
,
Alzheimer's disease
,
CMS
,
clinical trials
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.